Prosecution Insights
Last updated: October 04, 2026

Raydiant Oximetry Inc.

Technology area: Medical Devices & Mechanical Engineering

4 pending office actions • 2 art units • 4 examiners • 0 of 4 (0%) have an AI response strategy ready • 4 patents granted in the last 365 days

Analysis

Raydiant Oximetry Inc. has 4 pending office actions within the Medical Devices & Mechanical Engineering technology area. These matters are spread across 4 distinct examiners and 2 distinct art units. The use of 4 distinct examiners for the active matters indicates a distributed prosecution workload, where no single individual has an outsized influence on the portfolio's progress.

Jay B Shah is the busiest examiner for the portfolio, currently overseeing 1 pending office action. With 2 distinct art units involved, the company's active matters are concentrated in a limited number of technical divisions despite the variety of examiners. This structure suggests that the company's medical device innovations fall into two primary sub-categories at the patent office.

Practitioners should note that with multiple examiners, the prosecution strategy must be flexible enough to address different examination styles. However, the concentration in just two art units allows for some consistency in the technical arguments presented. The goal is to move the active actions forward by understanding the specific requirements of each assigned examiner while maintaining a cohesive narrative across the assigned units.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

4
Total Pending OAs
3
Non-Final OAs
1
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

0
Overdue
0
Due this week
0
Due this month
1
Due in next 60 days
0
Due later

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

3
Hard (75%)
1
Medium (25%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 + other3 (75%)
§103 only1 (25%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

0
Life Sciences
0% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
3
Mechanical / Eng
75% of docket
1
Business / Other
25% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

40 h
Manual time on pending OAs
8 h
Time saved (low, 20%)
14 h
Time saved (mid, 35%)
0.3 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
SHAH, JAY B 1 57.8% +6.5%
HOEKSTRA, JEFFREY GERBEN 1 56.5% +39.1%
STRACHAN, KATE ELIZABETH 1 48.2% +29.2%
KRETZER, KYLE W. 1 64.8% +41.5%

Hard Cases (3)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 3 ordered by deadline are shown.

App #TitleExaminerDue in
18576671 SYSTEMS, DEVICES, AND METHODS FOR PERFORMING TRANS-ABDOMINAL FETAL OXIMETRY AND/OR TRANS-ABDOMINAL FETAL PULSE OXIMETRY USING DC OXIMETRY MEASUREMENTS KRETZER, KYLE W. 39d
19002127 SYSTEMS, DEVICES, AND METHODS FOR DEVELOPING A MODEL FOR USE WHEN PERFORMING OXIMETRY AND/OR PULSE OXIMETRY AND SYSTEMS, DEVICES, AND METHODS FOR USING A FETAL OXIMETRY MODEL TO DETERMINE A FETAL OXIMETRY VALUE SHAH, JAY B —
18875109 SYSTEMS, DEVICES, AND METHODS FOR DETERMINING AN OXIMETRY VALUE USING A PERSONALIZED CALIBRATION EQUATION AND/OR TISSUE MODEL HOEKSTRA, JEFFREY GERBEN —

Interview Candidates (3)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.

App #TitleExaminerDue in
18576671 SYSTEMS, DEVICES, AND METHODS FOR PERFORMING TRANS-ABDOMINAL FETAL OXIMETRY AND/OR TRANS-ABDOMINAL FETAL PULSE OXIMETRY USING DC OXIMETRY MEASUREMENTS KRETZER, KYLE W. 39d
18875109 SYSTEMS, DEVICES, AND METHODS FOR DETERMINING AN OXIMETRY VALUE USING A PERSONALIZED CALIBRATION EQUATION AND/OR TISSUE MODEL HOEKSTRA, JEFFREY GERBEN —
18756562 SURGICAL DRAINS AND SYSTEMS AND METHODS FOR USING SAME STRACHAN, KATE ELIZABETH —

Top Art Units

Art UnitApps
3791 2
3781 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
19002127 SYSTEMS, DEVICES, AND METHODS FOR DEVELOPING A MODEL FOR USE WHEN PERFORMING OXIMETRY AND/OR PULSE OXIMETRY AND SYSTEMS, DEVICES, AND METHODS FOR USING A FETAL OXIMETRY MODEL TO DETERMINE A FETAL OXIMETRY VALUE SHAH, JAY B — §101DP Non-Final OA — Pending Dec 26, 2024
18875109 SYSTEMS, DEVICES, AND METHODS FOR DETERMINING AN OXIMETRY VALUE USING A PERSONALIZED CALIBRATION EQUATION AND/OR TISSUE MODEL HOEKSTRA, JEFFREY GERBEN 3791 §101§102§112 Non-Final OA — Pending Dec 13, 2024
18756562 SURGICAL DRAINS AND SYSTEMS AND METHODS FOR USING SAME STRACHAN, KATE ELIZABETH 3781 §103 Final Rejection — Pending Jun 27, 2024
18576671 SYSTEMS, DEVICES, AND METHODS FOR PERFORMING TRANS-ABDOMINAL FETAL OXIMETRY AND/OR TRANS-ABDOMINAL FETAL PULSE OXIMETRY USING DC OXIMETRY MEASUREMENTS KRETZER, KYLE W. 3791 §101§112 Non-Final OA 39d Pending Jan 04, 2024

Managing Raydiant Oximetry Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month